Also, hypoadiponectinemia related to systemic inflammation may have a role in the development of NAFLD [55] because adiponectin has anti-inflammatory effects via inhibition of tumor necrosis factor (TNF)-α and IL-6 [56]. Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.